TRPC1 and neoplasm: Moreover, SOCE was inhibited by BTP2 and 10 μM La3+, which block SOCs contributed by Orai1 and TRPC1 in a growing number of cell types [36, 62–65], including tumor-associated ECFCs [24, 25].